Meeting Program
 |
To view program in "24 hour" time (international) click here. |
| Sunday, February 6 | ||
|---|---|---|
| 3:00 - 7:30 PM | Registration | Longs Peak Foyer |
| 6:30 - 7:30 PM | Refreshments | Longs Peak Foyer |
| 7:30 - 8:30 PM |
Keynote Address Registered attendees for this meeting can view Abstracts for this session starting on 01/06/2011 |
Longs/Grays Peak |
|
Lee M. Nadler†,
Dana Farber Cancer Institute, USA
30 Years of Antibody Therapy for Cancer |
||
| Monday, February 7 | ||
| 7:00 - 8:00 AM | Breakfast | Quandary Peak |
| 8:00 - 11:00 AM |
New Antibody Platform Technologies I: Fc Modifications, Bispecifics, and Fragments Registered attendees for this meeting can view Abstracts for this session starting on 01/06/2011 |
Longs/Grays Peak |
|
Patrick A. Baeuerle,
Micromet, Inc., USA
Bispecific Antibodies Designed for Polyclonal T Cell Engagement |
||
|
Ian M. Tomlinson,
Domantis Limited, UK
Domain Antibodies for Human Therapy |
||
|
Jeffrey V. Ravetch,
Rockefeller University, USA
Hypersialylated Antibodies and Antibody Fragments for Immunomodulation |
||
|
George J. Weiner,
University of Iowa, USA
CDC and ADCC: Synergistic or Antagonistic Mechanisms for Antibody Drugs |
||
| 9:20 - 9:40 AM | Coffee Break | Longs Peak Foyer |
| 11:00 AM- 1:00 PM | Poster Setup | Quandary Peak |
| 1:00 - 10:00 PM | Poster Viewing | Quandary Peak |
| 4:30 - 5:00 PM | Coffee Available | Longs Peak Foyer |
| 5:00 - 7:00 PM |
New Antibody Platform Technologies II: Payloads Registered attendees for this meeting can view Abstracts for this session starting on 01/06/2011 |
Longs/Grays Peak |
|
John M. Lambert,
ImmunoGen, Inc., USA
Maytansinoid Drug Conjugates |
||
|
Peter D. Senter,
Seattle Genetics Inc., USA
Auristatin Drug Conjugates |
||
|
Nils Lonberg,
Bristol-Myers Squibb, USA
Alkylating Agent Drug Conjugates |
||
|
Mark X. Sliwkowski†,
Genentech, Inc., USA
Engineered Antibodies for Site-Directed Conjugation of Cytotoxic Drugs |
||
| 7:00 - 8:00 PM | Social Hour w/ Lite Bites | Quandary Peak |
| 7:30 - 10:00 PM |
Poster Session 1 Registered attendees for this meeting can view Abstracts for this session starting on 01/06/2011 |
Quandary Peak |
| Tuesday, February 8 | ||
| 7:00 - 8:00 AM | Breakfast | Quandary Peak |
| 8:00 - 11:00 AM |
Immune Modulation I: Infectious Disease Registered attendees for this meeting can view Abstracts for this session starting on 01/06/2011 |
Longs/Grays Peak |
|
Ian A. Wilson,
The Scripps Research Institute, USA
Antibody Recognition of HIV-1 and Influenza |
||
|
Andrea Lynn Cox,
Johns Hopkins University, USA
Antibody-Mediated HCV Immunotherapy |
||
|
James E. Crowe, Jr.,
Vanderbilt University Medical Center, USA
Naturally Occurring Human Antibody Responses to Viral Infections |
||
|
Gary J. Nabel†,
National Institutes of Health, USA
Neutralizing Anti-Viral Antibodies |
||
|
E. John Wherry†,
University of Pennsylvania, USA
Multiple Pathway Blockade for Re-Activation of Viral Infection Exhausted T Cells |
||
| 9:20 - 9:40 AM | Coffee Break | Longs Peak Foyer |
| 11:00 AM- 1:00 PM | Poster Setup | Quandary Peak |
| 1:00 - 10:00 PM | Poster Viewing | Quandary Peak |
| 4:30 - 5:00 PM | Coffee Available | Longs Peak Foyer |
| 5:00 - 7:00 PM |
Immune Modulation II: Tumor Immunotherapy Registered attendees for this meeting can view Abstracts for this session starting on 01/06/2011 |
Longs/Grays Peak |
|
Rachel Humphrey,
Bristol-Myers Squibb Company, USA
CTLA-4 Blockade for Cancer Immunotherapy |
||
|
Suzanne L. Topalian,
Johns Hopkins University School of Medicine, USA
PD-1 Blockade for Cancer Immunotherapy |
||
|
Drew M. Pardoll†,
Johns Hopkins University School of Medicine, USA
Checkpoint Blockade Combination Therapies |
||
| 7:00 - 8:00 PM | Social Hour w/ Lite Bites | Quandary Peak |
| 7:30 - 10:00 PM |
Poster Session 2 Registered attendees for this meeting can view Abstracts for this session starting on 01/06/2011 |
Quandary Peak |
| Wednesday, February 9 | ||
| 7:00 - 8:00 AM | Breakfast | Quandary Peak |
| 8:00 - 11:00 AM |
Immune Modulation III: Inflammatory Disease Registered attendees for this meeting can view Abstracts for this session starting on 01/06/2011 |
Longs/Grays Peak |
|
Trudi M. Veldman,
Abbott Bioresearch Center, USA
Modulation of the IL-1 Axis for RA and OA Using DVD-Ig Technology |
||
|
Speaker to be Announced,
|
||
|
Barbara White,
MedImmune, USA
IFN-alpha Blockade |
||
|
Speaker to be Announced,
|
||
| 9:20 - 9:40 AM | Coffee Break | Longs Peak Foyer |
| 11:00 AM- 1:00 PM | Poster Setup | Quandary Peak |
| 1:00 - 10:00 PM | Poster Viewing | Quandary Peak |
| 4:30 - 5:00 PM | Coffee Available | Longs Peak Foyer |
| 5:00 - 7:00 PM |
Cancer I Registered attendees for this meeting can view Abstracts for this session starting on 01/06/2011 |
Longs/Grays Peak |
|
Stephen M. Ansell,
Mayo Clinic, USA
Therapeutic Antibody Combinations in the Treatment of Lymphoproliferative Disorders |
||
|
Ronald Levy,
Stanford University, USA
Combination Therapy to Enhance Antibody ADCC Activity: CD137 MAbs as an Activator of NK Cell Function |
||
|
Jan van de Winkel,
Genmab, Netherlands
CD38 as a Target for MM |
||
| 7:00 - 8:00 PM | Social Hour w/ Lite Bites | Quandary Peak |
| 7:30 - 10:00 PM |
Poster Session 3 Registered attendees for this meeting can view Abstracts for this session starting on 01/06/2011 |
Quandary Peak |
| Thursday, February 10 | ||
| 7:00 - 8:00 AM | Breakfast | Quandary Peak |
| 8:00 - 11:00 AM |
Cancer II Registered attendees for this meeting can view Abstracts for this session starting on 01/06/2011 |
Longs/Grays Peak |
|
Edith Perez,
Mayo Clinic, USA
Targeting Her2+ Breast Cancer with Antibodies and/or TKIs: Combination or Competition |
||
|
Georgiana K. Ellis,
Seattle Cancer Care Alliance, USA
Cancer, Bone Health and Denosumab |
||
|
Eric Sievers,
Seattle Genetics, Inc., USA
CD30 Antibody-Drug Conjugate for Hodgkin’s Disease |
||
|
Barbara Klencke,
Genentech, Inc., USA
Herceptin-DM1 Antibody-Drug Conjugate |
||
| 9:20 - 9:40 AM | Coffee Break | Longs Peak Foyer |
| 4:30 - 5:00 PM | Coffee Available | Longs Peak Foyer |
| 5:00 - 7:00 PM |
Cancer III Registered attendees for this meeting can view Abstracts for this session starting on 01/06/2011 |
Longs/Grays Peak |
|
Ronald P. Taylor,
University of Virginia School of Medicine, USA
Antigen Shaving as a Mechaism of Resistance to Antibody Therapy |
||
|
Speaker to be Announced,
|
||
|
Roy S. Herbst,
University of Texas MD Anderson Cancer Center, USA
Antibodies Targeting Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor in Advanced Non-Small Cell Lung Cancer |
||
| 7:00 - 8:00 PM | Social Hour w/ Lite Bites | Quandary Peak |
| 8:00 - 11:00 PM | Entertainment | Quandary Peak |
| Friday, February 11 | ||
| Departure | ||
| *=Session Chair †=Speaker invited, not yet responded. | ||
Keystone Symposia would like to thank the sponsors of this meeting for their generous support:
We gratefully acknowledge additional support for this conference from:
|
MedImmune |
We gratefully acknowledge the organizations that provide Keystone Symposia with additional support, such as marketing and advertising...
Click here to view these companies